Tissue regeneration during wound healing or
cancer growth and progression depends on the establishment
of a cellular microenvironment. Mesenchymal stem
cells (MSC) are part of this cellular microenvironment,
where they functionally modulate cell homing, angiogenesis,
and immune modulation. MSC recruitment involves
detachment of these cells from their niche, and finally MSC
migration into their preferred niches; the wounded area, the
tumor bed, and the BM, just to name a few. During this
recruitment phase, focal proteolysis disrupts the extracellular
matrix (ECM) architecture, breaks cell–matrix
interactions with receptors, and integrins, and causes the
release of bioactive fragments from ECM molecules. MSC
produce a broad array of proteases, promoting remodeling
of the surrounding ECM through proteolytic mechanisms.
The fibrinolytic system, with its main player plasmin, plays
a crucial role in cell migration, growth factor bioavailability,
and the regulation of other protease systems during
inflammation, tissue regeneration, and cancer. Key components
of the fibrinolytic cascade, including the urokinase
plasminogen activator receptor (uPAR) and plasminogen
activator inhibitor-1 (PAI-1), are expressed in MSC. This
review will introduce general functional properties of the
fibrinolytic system, which go beyond its known function of
fibrin clot dissolution (fibrinolysis). We will focus on the
role of the fibrinolytic system for MSC biology, summarizing
our current understanding of the role of the
fibrinolytic system for MSC recruitment and the functional
consequences for tissue regeneration and cancer. Aspects
of MSC origin, maintenance, and the mechanisms by
which these cells contribute to altered protease activity in
the microenvironment under normal and pathological
conditions will also be discussed.